Exclusive
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Dr Agarwal's Healthcare IPO Opens for Subscription, Sees 6% Bids on Day 1

Written by : Nikita Saha

January 30, 2025

Category Img

The IPO includes a significant OFS component of INR 2,727 Cr. On the second day of bidding, the retail portion saw a 9% subscription, while non-institutional investors subscribed to 4%. Qualified institutional buyers had not yet placed bids.

The INR 3,027 Cr initial public offering (IPO) of Dr Agarwal's Healthcare, a leading eyecare service provider, opened for subscription on Wednesday, receiving an overall subscription of 6% as of 2:40 PM on the first day of bidding. Investors can subscribe to the issue until January 31.

The IPO includes a significant offer for sale (OFS) component of INR 2,727 Cr. On the second day of bidding, the retail portion saw a 9% subscription, while non-institutional investors subscribed to 4%. Qualified institutional buyers had not yet placed bids.

Ahead of its listing, Dr Agarwal's Healthcare was trading at a Grey Market Premium (GMP) of INR 8 on Wednesday, reflecting a 2% premium over the upper end of the price band of INR 402 per share. The GMP had dropped from INR 12 earlier.

The IPO is available within a price range of INR 382- INR 402 per share. Investors can bid for a minimum of one lot, with each lot comprising 35 shares.

Despite the large OFS component and premium valuation, analysts have recommended subscribing for long-term investment. The company is valued at 134 times its FY24 earnings per share (EPS) at the upper price band, with an estimated post-IPO market capitalization of INR 12,698 Cr.

"The company holds around 25% of its market share in the eye care services industry. We believe the issue is richly priced and recommend a 'Subscribe – Long Term' rating for the IPO," said Anand Rathi in a note.

Dr Agarwal's Healthcare provides a wide range of eye care services, including cataract and refractive surgeries, diagnostics, non-surgical treatments, and the sale of optical products, contact lenses, and pharmaceuticals. The company accounted for 25% of India's total eye care services market in FY24, serving 2.13 million patients and performing over 220,000 surgeries.

The firm operates on a hub-and-spoke model, with 28 hubs and 165 spokes across India as of September 2024.

According to a CRISIL report, India’s eye care industry is expected to grow at a CAGR of 12%-14% between FY24 and FY28, offering significant expansion opportunities for the company.

Stay tuned for more such updates on Digital Health News


More from this Author

POPULAR CATEGORIES

WEEKLY POPULAR POSTS

ABOUT US

Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

CONTACT US

© Digital Health News 2025